A phase II study of gemcitabine and capecitabine in metastatic renal cancer: a report of Cancer and Leukemia Group B protocol 90008.

Source:http://linkedlifedata.com/resource/pubmed/id/16909426

Cancer 2006 Sep 15 107 6 1273-9

Download in:

View as

Triples

General Info

PMID
16909426